Venture Spotlight Series November

Series Sponsor:

In today’s financial environment it extremely important to understand the likelihood of exit opportunities and develop a strategy to provide your investors with liquidity. While Wall Street may have lost its appetite for Biotech, Big Pharma’s appetite has never been greater. So what are the expectations of Venture Capitalists, what do they see as a valid Return on Investment, and which opportunities are they pursuing? Come participate in our Investor Spotlight and listen to what top tier VCs are saying. It may be just what you need to get your idea off the ground, and your valuation may hang in the balance.

• Topic: Winning the Race from the Start – Defining your Exit Strategy Before Raising Capital
  
• When: November 13, 2008
  Breakfast: 8:00am - 8:30am Presentations: 8:30am - 9:30am Networking: 9:30am - 10:00am
• Where: NYSE, 845 Page Mill Road, Palo Alto, CA
• Attire: Business Attire Suggested
• Cost: Advance - $10.00; At the Door - $20.00
  
• Register Here

For more information contact: Jessica Knowles at 650-871-7101 x214 or jknowles@baybio.org.

The BayBio Institute, in partnership with the NYSE, presents the BayBioNEST Venture Spotlight Series. This unique forum allows investors to speak directly to entrepreneurs in a reverse pitch format. Investors have the pulpit to discuss their current interests, target markets, therapies and technologies, as well as the maturation level of typical companies of interest.

The Venture Spotlights are held the second Thursday every month with each meeting focusing on up to three Northern California venture funds. Q&A, as well as the networking time will be provided following investor presentations.



With Additional Support From: